Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Equillium Inc (EQ)
NASDAQ:EQ
Equillium (EQ) Stock Price & Analysis
569 Followers
EQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.52 - $3.36
Previous Close$0.73
Volume74.05K
Average Volume (3M)189.84K
Market Cap
$25.12M
Enterprise Value-$35.72M
Total Cash (Recent Filing)$71.02M
Total Debt (Recent Filing)$10.19M
Price to Earnings (P/E)-0.4
Beta0.87
Next Earnings
May 11, 2023EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.90
Shares Outstanding34,414,149
10 Day Avg. Volume67,129
30 Day Avg. Volume189,839
Standard Deviation0.37
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.78
Price to Sales (P/S)1.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-3.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.27
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.58
Forecast
1Y Price Target
$5.60Price Target Upside667.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Equillium News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EQ FAQ
What was Equillium Inc’s price range in the past 12 months?
Equillium Inc lowest stock price was $0.52 and its highest was $3.36 in the past 12 months.
What is Equillium Inc’s market cap?
Currently, no data Available
When is Equillium Inc’s upcoming earnings report date?
Equillium Inc’s upcoming earnings report date is May 11, 2023 which is in 39 days.
How were Equillium Inc’s earnings last quarter?
Equillium Inc released its earnings results on Mar 23, 2023. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.196 by -$0.116.
Is Equillium Inc overvalued?
According to Wall Street analysts Equillium Inc’s price is currently Undervalued.
Does Equillium Inc pay dividends?
Equillium Inc does not currently pay dividends.
What is Equillium Inc’s EPS estimate?
Equillium Inc’s EPS estimate is -$0.26.
How many shares outstanding does Equillium Inc have?
Equillium Inc has 34,414,150 shares outstanding.
What happened to Equillium Inc’s price movement after its last earnings report?
Equillium Inc reported an EPS of $0.08 in its last earnings report, missing expectations of $0.196. Following the earnings report the stock price went up 10.769%.
Which hedge fund is a major shareholder of Equillium Inc?
Among the largest hedge funds holding Equillium Inc’s share is Cota Capital Management, LLC. It holds Equillium Inc’s shares valued at 596K.
---
Equillium Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.60 (667.12% Upside)
$5.60 (667.12% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 8.4%
Last 30 Days ▼ 8.4%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.82%
12-Months-Change
Fundamentals
Return on Equity
-126.83%
Trailing 12-Months
Asset Growth
-8.18%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Equillium Inc
Equillium, Inc. is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline include EQ001, is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.
---
Top 5 ETFs holding EQ
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold EQ. The ETFs are listed according to market value of EQ within the ETF
---
Inozyme Pharma
―
Bioxytran
―
Brainstorm Cell Therapeutics
―
Surface Oncology
―
Hookipa Pharma
―
---